COLOPLAST -B- receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- English (USA)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- English (Nigeria)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Coloplast A/S (COLOb)
Assess today's live Coloplast A/S (COLOb) share price, performance and insights using our live Copenhagen: COLOb stock exchange data.
Analyse the historical data and Coloplast A/S share price performance charts on this page. Our technical summary section provides analysis on Coloplast share price buy/sell indicators using real-time data (or discuss the Coloplast (COLOb) stock price today with other investors in the Coloplast CSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current CSE COLOb share price (ISIN: DK0060448595) to enhance your trading decisions with our free investment tools and resources.
What Is the Coloplast A/S Share Price Today?
The Coloplast share price today is 484.3.
What Is the Stock Symbol for Coloplast A/S
The stock symbol (or 'ticker') for Coloplast A/S is "COLOb."
What Stock Exchange Does Coloplast A/S Trade On?
Coloplast A/S is listed and trades on the Copenhagen stock exchange.
Is Coloplast A/S a Good Stock to Buy?
Determining whether Coloplast A/S—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
Analyse the historical data and Coloplast A/S share price performance charts on this page. Our technical summary section provides analysis on Coloplast share price buy/sell indicators using real-time data (or discuss the Coloplast (COLOb) stock price today with other investors in the Coloplast CSE share price and sentiment chat forum).
Use the dropdown to select a relevant stock exchange for the current CSE COLOb share price (ISIN: DK0060448595) to enhance your trading decisions with our free investment tools and resources.
What Is the Coloplast A/S Share Price Today?
The Coloplast share price today is 484.3.
What Is the Stock Symbol for Coloplast A/S
The stock symbol (or 'ticker') for Coloplast A/S is "COLOb."
What Stock Exchange Does Coloplast A/S Trade On?
Coloplast A/S is listed and trades on the Copenhagen stock exchange.
Is Coloplast A/S a Good Stock to Buy?
Determining whether Coloplast A/S—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, investors can sign up to InvestingPro, where they can assess share price, fair value and other essential metrics.
483.3
+2.3(+0.48%)
Real-time Data·
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
476.5
487.7
52 wk Range
476.5
810.2
Trading near 52-week Low
1/3
Fair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
476.5487.7
52 wk Range
476.5810.2
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.78%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(4.78%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
COLOb Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a stock's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Neutral
Price Target
615.1
Upside
+27.26%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
4 analysts have revised their earnings downwards for the upcoming period
- COLOPLAST -B- receives Investment Bank Analyst Rating Update
- Investing.com
Pro - COLOPLAST -B- receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- COLOPLAST -B- receives Investment Bank Analyst Rating Update
- Investing.com
Pro - COLOPLAST -B- receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Sell
Coloplast Company Profile
Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Dressings and Biologics segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; Peristeen Plus, a transanal irrigation system; and Peristeen Light, a low-volume transanal irrigation. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as erectile dysfunction, urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
Compare COLOb to Peers and Sector
Metrics to compare | COLOb | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipCOLObPeersSector | |
|---|---|---|---|---|
P/E Ratio | 27.5x | 27.5x | −0.5x | |
PEG Ratio | −1.50 | 0.08 | 0.00 | |
Price/Book | 8.0x | 2.7x | 2.6x | |
Price / LTM Sales | 3.9x | 2.6x | 3.3x | |
Upside (Analyst Target) | 26.4% | 0.0% | 45.0% | |
Fair Value Upside | Unlock | 23.4% | 5.1% | Unlock |
Analyst Ratings
4 Buy
14 Hold
1 Sell
Ratings:
19 analysts
Overall Consensus
Neutral
Analysts 12-Month Price Target:
Average 615.1
(+27.26% Upside)
Earnings
Latest Release
Feb 06, 2026
EPS / Forecast
6.32 / 6.35
Revenue / Forecast
7.04B / 7.17B
People Also Watch
FAQ
What Is the Coloplast (COLOb) Share Price Today?
The live Coloplast share price today is 483.3
What Stock Exchange Does Coloplast (COLOb) Trade On?
Coloplast is listed and trades on the Copenhagen Stock Exchange.
What Is the Ticker (Stock Symbol) for Coloplast?
The stock symbol (also called a 'ticker') for Coloplast is "COLOb."
Does Coloplast Pay Dividends? What’s The Current COLOb Dividend Yield?
Yes, COLOb Pays Dividends to its Shareholders. The current Coloplast dividend yield is 4.78%.
What Is the Current Coloplast Market Cap?
As of today, Coloplast market capitalisation is 109.07B.
What Is Coloplast's (COLOb) Earnings Per Share (TTM)?
The Coloplast EPS is currently 17.70 (Trailing Twelve Months).
When Is the Next Coloplast Earnings Date?
Coloplast's next earnings report will be released on 11 May 2026.
Is COLOb a Buy or Sell From a Technical Analyst Perspective?
Based on today's Coloplast moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Coloplast Stock Split?
Coloplast has split 5 times. (See the COLOb stock split history page for full effective split date and price information.)
How Many Employees Does Coloplast Have?
Coloplast has 16983 employees.
What is the current trading status of Coloplast (COLOb)?
As of 10 Feb 2026, Coloplast (COLOb) is trading at a price of 483.3, with a previous close of 481.0. The stock has fluctuated within a day range of 476.5 to 487.7, while its 52-week range spans from 476.5 to 810.2.
What Is Coloplast (COLOb) Price Target According to Analysts?
The average 12-month price target for Coloplast is DKK615.1, with a high estimate of DKK760 and a low estimate of DKK470. 4 analysts recommend buying the stock, while 1 suggest selling, leading to an overall rating of Neutral. The stock has an +27.26% Upside potential.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.